BRAINSTORM CELL THERAPEUTICS INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Brainstorm Cell Therapeutics Inc. Return On Assets for the quarter ending June 30, 2024 was -269 %, a 6.88% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2023 was -293 %, a 100% decline from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2022 was -146 %, a 131% decline from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2021 was -63.3 %, a 39.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -293 -146 -100% Jan 1, 2023 Dec 31, 2023
2022 -146 -82.9 -131% Jan 1, 2022 Dec 31, 2022
2021 -63.3 +41.7 +39.7% Jan 1, 2021 Dec 31, 2021
2020 -105 +160 +60.4% Jan 1, 2020 Dec 31, 2020
2019 -265 -165 -164% Jan 1, 2019 Dec 31, 2019
2018 -101 -50.9 -102% Jan 1, 2018 Dec 31, 2018
2017 -49.8 -9.49 -23.6% Jan 1, 2017 Dec 31, 2017
2016 -40.3 +3.13 +7.21% Jan 1, 2016 Dec 31, 2016
2015 -43.4 +53.8 +55.4% Jan 1, 2015 Dec 31, 2015
2014 -97.3 +3.32 +3.3% Jan 1, 2014 Dec 31, 2014
2013 -101 -8.85 -9.65% Jan 1, 2013 Dec 31, 2013
2012 -91.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.